Piramal, Pharma

Piramal Pharma Limited annuncia i risultati consolidati per il primo trimestre dell'esercizio 2025

Published on 08/07/2025 at 18:07 | prnewswire.co.uk

Piramal Pharma Ltd Italy India United States of America United Kingdom Canada France Germany Spain

| LinkedIn

 # EIR - Establishment Inspection Report * Include una struttura tramite l'investimento di minoranza di PPL in Yapan Bio.

Logo: https://mma.prnewswire.com/media/1855206/Piramal_Pharma_Limited_Logo.jpg

Cision View original content:https://www.prnewswire.com/it/comunicati-stampa/piramal-pharma-limited-annuncia-i-risultati-consolidati-per-il-primo-trimestre-dellesercizio-2025-302208148.html

en | boerse | 67937631 |